Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Access Pharma revealed plans for a China clinical trial...
China Sky One Medical (中国天字一号医药公司)...
A TCM, Fuzheng Huayu capsules, will begain a Phase...
China Sky One Medical (中国天字一号医药公司)...
Jiangsu Hengrui Medicine received FDA approval to begin...
China Sky One Medical (中国天字一号医药公司)...
In the ChinaBio® Executive Workshop,...
China Sky One Medical expects to have final SFDA approval...
Merck Serono will build a $250 million global R&D center...
China Sky One Medical (中国天字一号医药公司)...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
